À̴뼿ﺴ¿ø ´ëÇѽÅÀåÇÐȸ Á¦3ȸ »ç±¸Ã¼½Å¿°¿¬±¸È¸ ¿¬¼ö°Á : 2019-11-17±³À°ÀÏÀÚ : 2019-11-17
±³À°Àå¼Ò : À̴뼿ﺴ¿ø ´ë°´ç
±³À°ÁÖÁ¦ :
´ëÇѽÅÀåÇÐȸ Á¦3ȸ »ç±¸Ã¼½Å¿°¿¬±¸È¸ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : »ç±¸Ã¼½Å¿° ¿¬±¸È¸
´ã´çÀÚ : Á¶ÇöÁø
¿¬¶ôó : 031-787-7030
À̸ÞÀÏ :
10871@snubh.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ï : 20,000¿ø / ÇöÀåµî·Ï : 30,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-17 ´ë°´ç 12:30~13:00 Pathology of paraproteinemia related kidney disease ÀÓ¹üÁø(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 13:00~13:30 Clinical presentation of paraproteinemia related kidney disease ÀÌÁ¤Àº(¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 13:30~14:00 Treatment of paraproteinemia ÀÌÁ¤¿Á(ºÐ´ç¼¿ï´ëÇб³ º´¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 14:00~14:30 Functional studies for diagnosis of aHUS °Èñ°æ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 14:30~15:00 Disorders of renal development: nephronophthisis and ADTKD (MCKD) ÁöÇ念(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 15:00~15:30 Hereditary tubular disorder; Dent disease and Lowe syndrome Á¶Èñ¿¬(¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 15:30~16:00 Hereditary nephrotic syndrome Á¤ÇØÀÏ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 16:30~17:00 Management of recurrent MCD and FSGS ¿À¼¼¿ø(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 17:00~17:20 Prognosis of IgA nephropathy combined with minimal change disease ÀÌ»óÈ£(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 17:20~17:40 Renal outcome based on chronicity scoring system in IgA nephropathy ÃÖ¹ü¼ø(°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-17 ´ë°´ç 17:40~18:00 Prognosis of membranous nephropathy ÃÖÁö¿µ(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ)